ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.140
+0.020 (1.79%)
At close: Aug 28, 2026, 4:00 PM EDT
1.120
-0.020 (-1.74%)
After-hours: Aug 28, 2026, 7:30 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $145.54 million as of August 28, 2026. Its market cap has decreased by -59.82% in one year.
Market Cap
145.54M
Enterprise Value
364.63M
1-Year Change
-59.82%
Ranking
Category
Stock Price
$1.14
ChartMarket Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $145.54M, a decrease of -92.87%. That is a compound annual growth rate of -34.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 145.54M | -66.72% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akebia Therapeutics | 246.79M |
| Cardiol Therapeutics | 232.94M |
| SIGA Technologies | 220.22M |
| Organogenesis Holdings | 218.10M |
| Journey Medical | 212.25M |
| Organigram Global | 180.02M |
| Lifecore Biomedical | 176.02M |
| Cumberland Pharmaceuticals | 134.85M |